Antiretroviral therapy in the treatment-experienced patient

J. E. Gallant

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Despite the growing number of new antiretroviral agents, planning therapy for treatment-experienced patients remains extremely challenging. Cross-resistance within the three currently available classes of drugs limits the number of sequential drug regimens that can be expected to suppress viral replication effectively. An understanding of resistance and cross-resistance, together with judicious use of resistance testing, can help clinicians design better treatment regimens for patients experiencing virologic failure while taking antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)284-291
Number of pages8
JournalThe AIDS reader
Issue number4
StatePublished - 1999


  • Antiretroviral resistance
  • Antiretroviral therapy
  • Salvage therapy
  • Therapy, AIDS

ASJC Scopus subject areas

  • Virology
  • Medicine(all)


Dive into the research topics of 'Antiretroviral therapy in the treatment-experienced patient'. Together they form a unique fingerprint.

Cite this